Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA195538
Max Phase: Preclinical
Molecular Formula: C17H17FO
Molecular Weight: 256.32
Molecule Type: Small molecule
Associated Items:
ID: ALA195538
Max Phase: Preclinical
Molecular Formula: C17H17FO
Molecular Weight: 256.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(/C=C\c2ccc(C)c(C)c2)cc1F
Standard InChI: InChI=1S/C17H17FO/c1-12-4-5-14(10-13(12)2)6-7-15-8-9-17(19-3)16(18)11-15/h4-11H,1-3H3/b7-6-
Standard InChI Key: ALTBQLFTBMFPSU-SREVYHEPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 256.32 | Molecular Weight (Monoisotopic): 256.1263 | AlogP: 4.62 | #Rotatable Bonds: 3 |
Polar Surface Area: 9.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.32 | CX LogD: 5.32 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.73 | Np Likeness Score: -0.73 |
1. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP.. (2005) Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly., 48 (2): [PMID:15658859] [10.1021/jm049444m] |
Source(1):